# Shanghai Zhangjiang Science & Technology Venture Capital

Shanghai Zhangjiang Science & Technology Venture Capital is a Venture Capital based in Shanghai, China.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Assets under management:** Undisclosed
- **Website:** www.zjventure.com

## Regulatory record

- **Reports private funds:** No

## About

Shanghai Zhangjiang Science & Technology Venture Capital is a Shanghai-based investment company. It manages approximately $1.2 billion in assets across 50 funds, primarily focused on Asia.

## Sectors

- Enterprise Software
- AI/ML
- Industrial Tech
- Healthcare Services
- Mobility & Transportation

## Questions

### How does the firm's location inside Zhangjiang Hi-Tech Park influence its investment strategy?

The firm's physical location inside the park — Shanghai's largest concentration of semiconductor fabs, biotech labs, and software R&D centers — shapes its entire origination model. Rather than sourcing deals from a central office, it identifies startups through park-property relationships, shared-infrastructure usage, and tenant growth trajectories. This proximity means the firm can observe a company's laboratory expansion or cleanroom buildout before a formal fundraising process begins, creating a diligence timeline unavailable to off-park investors.

### Which sectors receive the largest allocation of capital?

Semiconductors, biotechnology, and enterprise software constitute the historical core, reflecting Zhangjiang Park's anchor tenants and the Shanghai municipal government's industrial priorities. Advanced manufacturing, particularly precision equipment used in chip fabrication, is also a recurring theme. The firm has been less active in consumer internet and pure marketplace models, which are better served by the venture ecosystem in Beijing and Shenzhen.

### Does the firm participate in fund commitments alongside other venture investors?

The firm predominantly makes direct equity investments rather than committing as a limited partner into independent venture funds. When external co-investors are involved, they tend to be other state-affiliated platforms, corporate venture arms of semiconductor or pharmaceutical companies, or select domestic RMB funds with complementary stage mandates. Foreign VC co-investment is uncommon given the structure of the underlying portfolio companies.

## Related profiles

- [Harris Preston & Partners](https://altss.com/profile/harris-preston-and-partners)
- [Queen's Health System Pension Plan](https://altss.com/profile/queens-health-system-pension-plan)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/shanghai-zhangjiang-science-and-technology-venture-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology